Vol 65, No 5 (2014)

Date published: 2014-10-10

Table of Contents

open access

paid access

Original papers

Incidence and predictors of persistent growth hormone deficiency (GHD) in patients with isolated, childhood-onset GHD

Joanna Smyczyńska, Renata Stawerska, Andrzej Lewiński, Maciej Hilczer

DOI: 10.5603/EP.2014.0046
Endokrynologia Polska 2014;65(5):334-341.

Serum resistin concentrations in children with type 1 diabetes mellitus — negative relation to body fat mass

Katarzyna Anna Majewska, Dominik Majewski, Bogda Skowrońska, Piotr Fichna

DOI: 10.5603/EP.2014.0047
Endokrynologia Polska 2014;65(5):342-347.

Transforming Growth Factor β1 (TGFβ1) and Vascular Endothelial Growth Factor (VEGF) in the blood of healthy people and patients with Graves’ orbitopathy — a new mechanism of glucocorticoids action?

Dariusz Kajdaniuk, Bogdan Marek, Danuta Niedziołka-Zielonka, Wanda Foltyn, Mariusz Nowak, Lucyna Siemińska, Halina Borgiel-Marek, Joanna Głogowska-Szeląg, Zofia Ostrowska, Lucjan Drożdż, Beata Kos-Kudła

DOI: 10.5603/EP.2014.0048
Endokrynologia Polska 2014;65(5):348-356.

Free and bioavailable fractions of sex steroids may influence bones in young men, depending on age and oestradiol level

Dorota Szyska-Skrobot, Katarzyna Marchlewska, Renata Walczak-Jędrzejowska, Elżbieta Oszukowska, Eliza Filipiak, Piotr Kula, Ryszard Mężyk, Aldona Kowalska, Ryszard Jaszewski, Jolanta Słowikowska-Hilczer, Krzysztof Kula

DOI: 10.5603/EP.2014.0049
Endokrynologia Polska 2014;65(5):357-364.

Semiquantitative assessment of hirsutism in 850 PCOS patients and 2,988 controls in China

Meifong Wong, Xiaomiao Zhao, Yu Hong, Dongzi Yang

DOI: 10.5603/EP.2014.0050
Endokrynologia Polska 2014;65(5):365-370.

Fetuin-A levels in lean and obese women with polycystic ovary syndrome

Jarosław Kozakowski, Wojciech Jeske, Wojciech Zgliczyński

DOI: 10.5603/EP.2014.0051
Endokrynologia Polska 2014;65(5):371-376.

Fasting and postprandial acyl and desacyl ghrelin levels in obese and non-obese subjects

Jolanta Anna Dardzińska, Sylwia Małgorzewicz, Łukasz Kaska, Monika Proczko, Tomasz Stefaniak, Marta Stankiewicz, Zbigniew Śledziński

DOI: 10.5603/EP.2014.0052
Endokrynologia Polska 2014;65(5):377-381.

Overexpression of prothymosin alpha is related to pituitary adenoma recurrence but not to adenoma invasiveness and proliferation

Marek Pawlikowski, Maciej Radek, Jolanta Kunert-Radek, Maria Jaranowska, Jacek Świętosławski, Katarzyna Winczyk

DOI: 10.5603/EP.2014.0053
Endokrynologia Polska 2014;65(5):382-386.
Review article

Orbital radiotherapy in the management of Graves’ orbitopathy — current state of knowledge

Marek Ruchała, Aleksandra Hernik, Ariadna Zybek

DOI: 10.5603/EP.2014.0054
Endokrynologia Polska 2014;65(5):388-396.
Case report

False diagnosis of type 1 diabetes mellitus and its complications in Wolfram syndrome — is it the reason for the low number of reported cases of this abnormality?

Katarzyna Homa, Adam Stefański, Agnieszka Zmysłowska, Piotr Molęda, Marta Ewa Bryśkiewicz, Liliana Majkowska

DOI: 10.5603/EP.2014.0055
Endokrynologia Polska 2014;65(5):398-400.
Postgraduate education

Is high dose intravenous methylprednisolone pulse therapy in patients with Graves’ orbitopathy safe?

Piotr Miśkiewicz, Adrianna Kryczka, Urszula Ambroziak, Beata Rutkowska, Renata Główczyńska, Grzegorz Opolski, George Kahaly, Tomasz Bednarczuk

DOI: 10.5603/EP.2014.0056
Endokrynologia Polska 2014;65(5):402-413.
Congressional papers

Abstracts

IV Zjazd Polskiego Towarzystwa Neuroendokrynologii

DOI: 10.5603/EP.2014.0057
Endokrynologia Polska 2014;65(5):415-439.

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl